Trials / Completed
CompletedNCT00875498
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hôpital le Vinatier · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the iTBS is an effective treatment of the negative symptoms of schizophrenia.
Detailed description
This study will evaluate whether the intermittent Theta Burst Stimulation (iTBS), a new high frequency TMS protocol is efficient in the treatment of the Negative Symptoms of schizophrenia. Neuroimaging studies demonstrate that hypoactivity in the left dorsolateral prefrontal cortex (LDLPFC) was associated with negative symptoms. The investigators hypothesize that iTBS applied to LDLPFC will improve negative symptoms and will improve activity of the LDLPFC measured with Magnetic Resonance Spectroscopy (MRS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | active iTBS | Intermittent Theta Burst Stimulation (iTBS) over Left dorsolateral prefrontal cortex. 80% MT, 20 sessions of 6 minutes, 2 per day |
| PROCEDURE | sham iTBS | iTBS placebo (placebo coil) |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2009-04-03
- Last updated
- 2016-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00875498. Inclusion in this directory is not an endorsement.